Andrew Hay

VP General Manager International at Apellis Pharmaceuticals

Renens, Vaud, Switzerland

About

A strategic marketing and sales professional with over 25 years commercial experience in pharmaceutical and biotechnology organisations. Success in rare/orphan diseases been achieved through an ability to develop a clear vision, a successfully executed strategy and leading a strong, highly motivated and empowered team to deliver targeted business. Experienced in leadership, marketing, product launches, sales, strategy, portfolio management, business development, project management, and change management

Experience

  • Apellis Pharmaceuticals (6 yrs 10 mos)
    • VP, General Manager International Region
      Feb 2025 - Present · 1 yr 5 mos

    • Vice President EU Commercial Operations
      Sep 2019 - Mar 2025 · 5 yrs 7 mos

    • VP General Manager UK & Nordics (Interim)
      Oct 2021 - Apr 2022 · 7 mos

  • Takeda Oncology (2 yrs 3 mos)
    • Myeloma Franchise Head, Oncology Business Unit Europe and Canada
      Mar 2019 - Aug 2019 · 6 mos

    • General Manager Ninlaro EUCAN
      Jun 2017 - Aug 2019 · 2 yrs 3 mos

  • Celgene (9 yrs 3 mos)
    • Senior Commercial Director European Marketing
      Feb 2013 - Sep 2015 · 2 yrs 8 mos

      Strategic Planning, Haematology, Multiple Myeloma, Product Launches, Rare Disease,Orphan Disease Disease team leader,

    • Haematology Business Unit Director
      Feb 2011 - Feb 2013 · 2 yrs 1 mo

      Sales, Marketing, Leadership Team, Haematology, Rare Disease,Product launches, Training, Mentoring, Key Account Management, Forecasting, Mutiple Myeloma

    • Head of Marketing
      Feb 2010 - Feb 2011 · 1 yr 1 mo

  • Senior Key Account Manager at Amgen UK
    Mar 2000 - Jul 2006 · 6 yrs 5 mos

  • Sales Representaive at GlaxoSmithKline New Zealand
    Nov 1992 - Dec 1998 · 6 yrs 2 mos